NASDAQ:RPID Rapid Micro Biosystems (RPID) Stock Price, News & Analysis → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free RPID Stock Alerts $0.99 +0.01 (+1.02%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$0.95▼$0.9950-Day Range$0.93▼$1.1052-Week Range$0.74▼$1.44Volume36,274 shsAverage Volume49,173 shsMarket Capitalization$42.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Rapid Micro Biosystems alerts: Email Address Rapid Micro Biosystems MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.44% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.93Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.09) to ($1.03) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.68 out of 5 starsMedical Sector765th out of 939 stocksAnalytical Instruments Industry23rd out of 28 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Rapid Micro Biosystems. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.44% of the float of Rapid Micro Biosystems has been sold short.Short Interest Ratio / Days to CoverRapid Micro Biosystems has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rapid Micro Biosystems has recently decreased by 10.98%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldRapid Micro Biosystems does not currently pay a dividend.Dividend GrowthRapid Micro Biosystems does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RPID. Previous Next 3.9 News and Social Media Coverage News SentimentRapid Micro Biosystems has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Rapid Micro Biosystems this week, compared to 1 article on an average week.Search Interest3 people have searched for RPID on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows1 people have added Rapid Micro Biosystems to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rapid Micro Biosystems insiders have not sold or bought any company stock.Percentage Held by Insiders32.39% of the stock of Rapid Micro Biosystems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.60% of the stock of Rapid Micro Biosystems is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Rapid Micro Biosystems are expected to grow in the coming year, from ($1.09) to ($1.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rapid Micro Biosystems is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rapid Micro Biosystems is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRapid Micro Biosystems has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here About Rapid Micro Biosystems Stock (NASDAQ:RPID)Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, onsite technical training, and customer support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. In addition, it offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; and RMBNucleus Central Manager portal streamlines monitoring and reporting. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.Read More RPID Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RPID Stock News HeadlinesMarch 26, 2024 | americanbankingnews.comRapid Micro Biosystems (NASDAQ:RPID) Trading Up 1%March 19, 2024 | globenewswire.comRapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024March 28, 2024 | Behind the Markets (Ad)The Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.March 17, 2024 | seekingalpha.comRPID Rapid Micro Biosystems, Inc.March 12, 2024 | globenewswire.comRapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor ForumMarch 8, 2024 | finanznachrichten.deRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 6, 2024 | globenewswire.comRapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 4, 2024 | finance.yahoo.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionMarch 3, 2024 | seekingalpha.comRapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finance.yahoo.comQ4 2023 Rapid Micro Biosystems Inc Earnings CallMarch 1, 2024 | msn.comRapid Micro Biosystems GAAP EPS of -$0.26 beats by $0.04, revenue of $6.34M beats by $0.19MMarch 1, 2024 | globenewswire.comRapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 GuidanceFebruary 27, 2024 | globenewswire.comRapid Micro Biosystems to Participate in Upcoming Investor ConferencesFebruary 27, 2024 | benzinga.comRapid Micro Biosystems Stock (NASDAQ:RPID), Quotes and News SummaryFebruary 21, 2024 | nz.finance.yahoo.comI Grew Up With Frugal Parents: 9 Things They Told Me To Never Waste Money OnFebruary 20, 2024 | finance.yahoo.comRapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024February 20, 2024 | globenewswire.comRapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024February 3, 2024 | msn.comRapid Micro Biosystems Faces Potential Nasdaq DelistingJanuary 10, 2024 | finanznachrichten.deRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 RevenueJanuary 10, 2024 | finanznachrichten.deRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct SystemJanuary 10, 2024 | msn.comRapid Micro Biosystems issues Q4 and FY23 guidanceJanuary 10, 2024 | finance.yahoo.comRapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 RevenueJanuary 10, 2024 | finance.yahoo.comRapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® SystemJanuary 4, 2024 | finance.yahoo.comSamsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testingJanuary 3, 2024 | finance.yahoo.comRapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare ConferenceDecember 15, 2023 | msn.comRapid Micro Biosystems files for $200M mixed shelfSee More Headlines Receive RPID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rapid Micro Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/01/2024Today3/28/2024Next Earnings (Estimated)5/03/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolNASDAQ:RPID CUSIPN/A CIK1380106 Webwww.rapidmicrobio.com Phone978-349-3200FaxN/AEmployees193Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-52,470,000.00 Net Margins-232.99% Pretax Margin-232.85% Return on Equity-39.02% Return on Assets-33.43% Debt Debt-to-Equity RatioN/A Current Ratio6.34 Quick Ratio5.29 Sales & Book Value Annual Sales$22.52 million Price / Sales1.87 Cash FlowN/A Price / Cash FlowN/A Book Value$2.78 per share Price / Book0.36Miscellaneous Outstanding Shares42,500,000Free Float28,732,000Market Cap$42.08 million OptionableNot Optionable Beta1.27 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Robert G. Spignesi Jr. (Age 54)CEO, President & Director Comp: $777.53kMr. Sean M. Wirtjes (Age 55)Chief Financial Officer Comp: $510.64kMr. John J. Addington Wilson (Age 56)Chief Operating Officer Comp: $512.94kMichael Beaulieu C.F.A.Vice President of Investor Relations & Corporate CommunicationsMr. Michael WysockiSenior Vice President of Sales & MarketingMs. Victoria L. Vezina (Age 56)Chief Human Resources Officer Comp: $366.36kMs. Kristine WilliamsSenior Vice President of Research & Development and Product ManagementMore ExecutivesKey CompetitorsSingular Genomics SystemsNASDAQ:OMICPrecision BioSciencesNASDAQ:DTILCue HealthNASDAQ:HLTHBionano GenomicsNASDAQ:BNGOTalis BiomedicalNASDAQ:TLISView All CompetitorsInsiders & InstitutionsGoldman Sachs Group Inc.Sold 729,494 shares on 3/1/2024Ownership: 0.515%Goldman Sachs Group Inc.Sold 729,494 shares on 2/13/2024Ownership: 0.515%Sean M WirtjesBought 10,000 shares on 9/6/2023Total: $9,900.00 ($0.99/share)Robert G Jr. SpignesiBought 20,000 shares on 8/15/2023Total: $19,400.00 ($0.97/share)Robert G Jr. SpignesiBought 20,000 shares on 5/17/2023Total: $18,200.00 ($0.91/share)View All Insider TransactionsView All Institutional Transactions RPID Stock Analysis - Frequently Asked Questions How have RPID shares performed in 2024? Rapid Micro Biosystems' stock was trading at $0.74 at the beginning of the year. Since then, RPID stock has increased by 33.8% and is now trading at $0.99. View the best growth stocks for 2024 here. When is Rapid Micro Biosystems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 3rd 2024. View our RPID earnings forecast. How were Rapid Micro Biosystems' earnings last quarter? Rapid Micro Biosystems, Inc. (NASDAQ:RPID) posted its earnings results on Friday, March, 1st. The company reported ($0.26) earnings per share for the quarter, beating analysts' consensus estimates of ($0.31) by $0.05. The company had revenue of $6.34 million for the quarter, compared to analyst estimates of $6.30 million. Rapid Micro Biosystems had a negative net margin of 232.99% and a negative trailing twelve-month return on equity of 39.02%. During the same quarter in the prior year, the company earned ($0.39) earnings per share. What guidance has Rapid Micro Biosystems issued on next quarter's earnings? Rapid Micro Biosystems issued an update on its FY 2024 earnings guidance on Friday, March, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $27.0 million-, compared to the consensus revenue estimate of $28.3 million. When did Rapid Micro Biosystems IPO? Rapid Micro Biosystems (RPID) raised $125 million in an IPO on Thursday, July 15th 2021. The company issued 6,600,000 shares at $18.00-$20.00 per share. Who are Rapid Micro Biosystems' major shareholders? Rapid Micro Biosystems' stock is owned by a number of institutional and retail investors. Top institutional investors include Goldman Sachs Group Inc. (0.51%) and Goldman Sachs Group Inc. (0.51%). Insiders that own company stock include Inese Lowenstein, Kennedy Lewis Management Lp, Robert G Jr Spignesi and Sean M Wirtjes. View institutional ownership trends. How do I buy shares of Rapid Micro Biosystems? Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RPID) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapid Micro Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.